Neuromuscular Disorders of Infancy, Childhood, and Adolescence (ePub)
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Neuromuscular disorders are diagnosed across the lifespan and create many challenges especially with infants, children and adolescents. This new edition of the definitive reference, edited by the established world renowned authorities on the science, diagnosis and treatment of neuromuscular disorders in childhood is a timely and needed resource for all clinicians and researchers studying neuromuscular disorders, especially in childhood. The Second Edition is completely revised to remain current with advances in the field and to insure this remains the standard reference for clinical neurologists and clinical research neurologists. The Second Edition retains comprehensive coverage while shortening the total chapter count to be an even more manageable and effective reference.
- Carefully revised new edition of the classic reference on neuromuscular disorders in infancy, childhood and adolescence.
- Definitive coverage of the basic science of neuromuscular disease and the latest diagnosis and treatment best practices.
- Includes coverage of clinical phenomenology, electrophysiology, histopathology, molecular genetics and protein chemistry
Dr. H. Royden Jones was Chair of the Department of Neurology at Lahey Hospital and Medical Center, Burlington, Massachusetts; Director of the Electromyography Laboratory at Boston Children’s Hospital; and Clinical
Associate Professor Monique Ryan is a paediatric neurologist in the Children’s Neurosciences Centre, Royal Children’s Hospital, Melbourne Australia, where she is head of the neuromuscular clinical research program and multidisciplinary Neuromuscular Clinic. This clinic oversees the care of more than 500 children with neuromuscular disorders. A/Prof Ryan’s research interests include natural history studies of paediatric neuropathies and clinical trials of new therapies for muscle diseases, neuropathies and myasthenic syndromes of childhood. Her group undertook the landmark initial study of treatment of paediatric Charcot-Marie-Tooth disease type 1A with ascorbic acid, the first randomized, double-blind placebo-controlled therapeutic trial in paediatric CMT. Other research trials previously or currently undertaken at RCH include trials of novel therapeutics for Duchenne muscular dystrophy and spinal muscular atrophy, a number of studies addressing the natural history of various forms of paediatric CMT, and studies identifying new genes for CMT. A/Prof Ryan is a member of several international neuromuscular research consortia, a board member of CINRG and a member of the extended TREAT-NMD therapeutic advisory committee.
Dr. Darryl C. De Vivo is the Sidney Carter Professor of Neurology, Professor of Pediatrics, and Director Emeritus (1979-2000) of the Pediatric Neurology Service at the Columbia University Medical Center in New York City. He also serves as the Associate Chairman for Pediatric Neurosciences and Developmental Neurobiology, the Founding Director of the Colleen Giblin Research Laboratories for Pediatric Neurology, and the Co-Director of the Center for Motor Neuron Biology and Disease (MNC). Dr. De Vivo was a Director for Neurology and President of the American Board of Psychiatry and Neurology, Secretary of the American Academy of Neurology, and President of the Child Neurology Society. He completed postgraduate training in medicine at the University of Virginia Medical School, and residency training in medicine, pediatrics, and neurology at the Massachusetts Memorial Hospital and the Massachusetts General Hospital, and at the National Institutes of Health where he was a Clinical Associate in Neurology. Dr. De Vivo receives federal and non-federal funding, and serves as the Director for the Pediatric Neuromuscular Clinical Research Network (PNCRN) in Spinal Muscular Atrophy. He has published more than 400 original articles and reviews, lectures extensively in the U.S. and abroad, and serves on several editorial boards and advisory committees. He was honored in 2014 by the American Academy of Neurology as the recipient of the Sidney Carter Award in Pediatric Neurology. He has devoted part of his professional career to the study of neuromuscular diseases. In 1967, he studied at the NINDS as a clinical associate under W. King Engel. In 1975, he and Michael Brooke established the Jerry Lewis Neuromuscular Disease Center at Washington University School of Medicine. In 1979, Dr. De Vivo established the Pediatric Neuromuscular Disease Center at the Columbia University Medical Center, and in 2004, with support from the New York-based SMA Foundation, the Center was expanded to include the SMA Clinical Research Center, an intramural affiliate of the MNC. Recently, the PNCRN, established in 2004, has been expanded to six academic sites at Columbia, Harvard, Penn, Rochester, Nemours/Orlando and Stanford. This network is dedicated to the acceleration of clinical trials in search of effective treatments for SMA.
- 2014, 2. Auflage, 1160 Seiten, Englisch
- Herausgegeben: Basil T. Darras, Jr. H. Royden Jones, Monique M. Ryan, Darryl C. De Vivo
- Verlag: Elsevier Science & Techn.
- ISBN-10: 0124171273
- ISBN-13: 9780124171275
- Erscheinungsdatum: 03.12.2014
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
- Dateiformat: ePub
- Grösse: 37 MB
- Mit Kopierschutz
- Vorlesefunktion
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Neuromuscular Disorders of Infancy, Childhood, and Adolescence".
Kommentar verfassen